University Hospital

Medicine & Life Sciences

1. Neoplasms 100%
2. Japan 85%
3. Non-Small Cell Lung Carcinoma 85%
4. Therapeutics 74%
5. Lung 55%
6. Lung Neoplasms 54%
7. Drug Therapy 54%
8. Survival 47%
9. Recurrence 44%
10. Mutation 44%
11. Neoplasm Metastasis 43%
12. Breast Neoplasms 43%
13. Kidney 40%
14. Tomography 39%
15. Tibial Meniscus 38%
16. Lung Transplantation 34%
17. Cisplatin 34%
18. Serum 34%
19. ErbB Receptors 34%
20. Genes 33%
21. Hepatocellular Carcinoma 33%
22. Radiofrequency Ablation 31%
23. Bone and Bones 30%
24. Transplants 28%
25. Living Donors 27%
26. Prostatic Neoplasms 27%
27. Cell Line 27%
28. Confidence Intervals 26%
29. Liver 26%
30. Retrospective Studies 26%
31. Small Cell Lung Carcinoma 26%
32. Safety 26%
33. Liver Transplantation 25%
34. Gefitinib 25%
35. Magnetic Resonance Imaging 25%
36. Stomach Neoplasms 25%
37. Biopsy 24%
38. Carcinoma 24%
39. Prospective Studies 23%
40. Cohort Studies 22%
41. Incidence 21%
42. Chemoradiotherapy 21%
43. Multicenter Studies 20%
44. Adenoviridae 20%
45. Tooth 20%
46. Pediatrics 20%
47. Lymph Nodes 20%
48. Radiotherapy 20%
49. Diabetic Nephropathies 20%
50. Wounds and Injuries 20%
51. Tears 19%
52. Stomach 19%
53. Odds Ratio 19%
54. Progression-Free Survival 18%
55. Proteins 18%
56. Systematic Reviews 18%
57. Apoptosis 18%
58. Child 18%
59. Seizures 17%
60. Hemorrhage 17%
61. Biomarkers 17%
62. Stents 17%
63. Squamous Cell Carcinoma 17%
64. Stroke 17%
65. Aneurysm 17%
66. Messenger RNA 17%
67. Urinary Bladder Neoplasms 16%
68. Atrial Heart Septal Defects 16%
69. Docetaxel 16%
70. Colorectal Neoplasms 16%
71. Elderly 16%
72. Eye 16%
73. Randomized Controlled Trials 16%
74. Brain 16%
75. Tissue Donors 16%
76. Pharmaceutical Preparations 16%
77. Protein-Tyrosine Kinases 16%
78. Thorax 15%
79. Knee 15%
80. Esophageal Neoplasms 15%
81. Survival Rate 15%
82. Renal Cell Carcinoma 15%
83. Cytokines 15%
84. Infections 15%
85. Endoscopic Mucosal Resection 15%
86. Meta-Analysis 15%
87. Growth 14%
88. Hematopoietic Stem Cell Transplantation 14%
89. Gene Expression 14%
90. Adenocarcinoma of Lung 14%
91. Electroencephalography 14%
92. In Vitro Techniques 14%
93. Lymphoma 14%
94. Hepatectomy 14%
95. Skin 14%
96. Pancreatic Neoplasms 14%
97. Doxorubicin 13%
98. Observational Studies 13%
99. Injections 13%
100. Inflammation 13%